✦ LIBER ✦

Expression of epidermal growth factor receptor (EGFR) is frequent in inflammatory bowel disease (IBD)-associated intestinal cancer

✍ Scribed by Magali Svrcek; Jacques Cosnes; Emmanuel Tiret; Malika Bennis; Yann Parc; Jean-François Fléjou

Book ID: 106117701
Publisher: Springer
Year: 2006
Tongue: English
Weight: 130 KB
Volume: 450
Category: Article
ISSN: 1432-2307
DOI: 10.1007/s00428-006-0338-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal Growth Factor Receptor (EGFR)

Epidermal Growth Factor Receptor (EGFR) Expression is Associated With a Worse Prognosis in Gastric Cancer Patients Undergoing Curative Surgery

✍ Gennaro Galizia; Eva Lieto; Michele Orditura; Paolo Castellano; Anna La Mura; Vi 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 297 KB

Inhibition of proliferation and inductio

Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level

✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant